As such, the methodology described here holds great promise to study the CD8+ T cell repertoire in patients with autoimmune diseases but also in HDs, thus providing the scientific community with the right tools to address fundamental questions on the development of autoreactive CD8+ T cells and how they can go rogue in autoimmunity. This evidence concerns the gene CD8A and Autoimmunity.